NEWSDaiichi Sankyo and Merck Report the P-II Study Data for Raludotatug Deruxtecan in Pt.-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube CancerByPrince GiriOctober 21, 20250Comments
NEWSRegeneron Reports the CHMP’s Positive Opinion for Adjuvant Libtayo to Treat High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)ByRidhi RastogiOctober 21, 20250Comments
WEEKLY SNAPSHOTPharmaShots Weekly Snapshots (Oct 13, 2025 – Oct 17, 2025) ByRidhi RastogiOctober 17, 20250Comments
VIDEOLIFE SCIENCES | DAILY NEWS | OCT 17, 2025 | PHARMASHOTSByDipanshu DixitOctober 17, 20250Comments
NEWSFDA Approves Celltrion’s Yuflyma (Biosimilar, Humira) and its Unbranded Version for Hidradenitis Suppurativa (HS) and Uveitis in Younger PatientsByRidhi RastogiOctober 17, 20250Comments
NEWSJohnson & Johnson Reports the US FDA’s sNDA Acceptance & Priority Review of Akeega to Treat Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)ByRidhi RastogiOctober 17, 20250Comments
NEWSMerck Highlights P-III (KEYNOTE-B96/ENGOT-ov65) Trial Findings on Keytruda for Platinum-Resistant Ovarian CancerByRidhi RastogiOctober 17, 20250Comments
NEWSLEO Pharma Reports the NMPA’s NDA Acceptance for Anzupgo (Delgocitinib) to Treat Chronic Hand Eczema (CHE)ByRidhi RastogiOctober 17, 20250Comments
NEWSLeads Biolabs and Dianthus Therapeutics Sign ~$1B Licensing Deal to Jointly Advance LBL-047ByRidhi RastogiOctober 17, 20250Comments
